AnaptysBio, Inc. ANAB Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s net gains (losses) on investments?
- AnaptysBio, Inc. (ANAB) reported net gains (losses) on investments of $8K in Q1 2026.
- How has AnaptysBio, Inc.'s net gains (losses) on investments changed year-over-year?
- AnaptysBio, Inc.'s net gains (losses) on investments decreased by 99.5% year-over-year, from $1.67M to $8K.
- What is the long-term trend for AnaptysBio, Inc.'s net gains (losses) on investments?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s net gains (losses) on investments has grown at a 76.0% compound annual growth rate (CAGR), from -$493K to $4.73M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.